Migablok 40mg/10mg Tablet is a combination medication containing Propranolol (40mg) and Flunarizine (10mg) indicated for the prophylactic treatment of migraines and prevention of episodic vasospasm. Propranolol, a beta blocker, helps to reduce the frequency and severity of migraines by decreasing blood pressure and vasospasm. Flunarizine, a calcium channel blocker, also contributes to the prevention of vasospasm and the reduction of migraine symptoms. This tablet is suitable for adult patients experiencing frequent or severe migraines, as well as those with a history of vasospasm. The recommended dose is one tablet taken orally twice daily. Migablok 40mg/10mg Tablet should be used with caution in patients with a history of depression, bronchial asthma, or chronic kidney disease. Patients should be monitored for any signs of decreased blood pressure or increased heart rate. The most common side effects include dizziness, lightheadedness, and fatigue. Patients should consult their doctor or pharmacist if they experience any adverse reactions.